Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Amortizatization of Intangibles (2017 - 2025)

VYNE Therapeutics' Amortizatization of Intangibles history spans 6 years, with the latest figure at -$214000.0 for Q2 2025.

  • For Q2 2025, Amortizatization of Intangibles rose 65.26% year-over-year to -$214000.0; the TTM value through Jun 2025 reached -$1.6 million, up 3.64%, while the annual FY2025 figure was -$778000.0, 68.15% up from the prior year.
  • Amortizatization of Intangibles reached -$214000.0 in Q2 2025 per VYNE's latest filing, up from -$324000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of -$214000.0 in Q2 2025 to a low of -$777000.0 in Q1 2024.
  • Average Amortizatization of Intangibles over 3 years is -$462285.7, with a median of -$506000.0 recorded in 2024.
  • Peak YoY movement for Amortizatization of Intangibles: tumbled 113.33% in 2024, then soared 65.26% in 2025.
  • A 3-year view of Amortizatization of Intangibles shows it stood at -$255000.0 in 2023, then crashed by 113.33% to -$544000.0 in 2024, then skyrocketed by 60.66% to -$214000.0 in 2025.
  • Per Business Quant, the three most recent readings for VYNE's Amortizatization of Intangibles are -$214000.0 (Q2 2025), -$324000.0 (Q1 2025), and -$544000.0 (Q4 2024).